Compare ARK Genomic Revolution ETF (ARKG) vs Toyota Motor Corp (TM) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Toyota Motor Corp — how do they compare? ARK Genomic Revolution ETF trades at $40.95, while Toyota Motor Corp trades at $174.77 (market cap $206.62B). The key difference: Toyota Motor Corp pays a 3.55% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Toyota Motor Corp nearer its low. Which is the better fit depends on your goals.
| ARKG | TM | |
|---|---|---|
Sector | Sector/Thematic | Consumer Cyclical |
52-Week High | $43.57 | $248.29 |
52-Week Low | $23.09 | $166.50 |
Market Cap | — | $206.62B |
Enterprise Value | — | $370.82B |
Dividend Yield | — | 3.55% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Toyota Motor (TM) trades at $176.45, up 1.22% today, with a neutral technical signal and strong fundamentals including a P/E of 9.67 and three consecutive quarterly EPS beats. The company announced a $3.6 billion Texas plant expansion to shift Tacoma production from Mexico, signaling strategic U.S. investment. Revenue grew to $48.04T in 2025, though net income dipped slightly to $4.77T, while cash flow trends show projected recovery in 2026.
TM presents a value opportunity with low valuation multiples and consistent profitability, but faces risks from competitive pressures and fluctuating margins. Analyst consensus is mixed with 37.5% buy ratings, reflecting cautious optimism amid hybrid vehicle strength and macroeconomic uncertainties. The stock's outlook hinges on execution of expansion plans and sustained demand for fuel-efficient models.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Toyota Motor Corp
Founded in 1937, Toyota is one of the world's largest automakers with 10.38 million units sold at retail in fiscal 2022 across its light vehicle brands. Brands include Toyota, Lexus, Daihatsu, and truck maker Hino.
Read more on TM →
